Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Safety Study of LY3372689 in Healthy Participants

This study is being conducted to determine the safety profile of the study drug after it is given by mouth to healthy participants. Blood tests will be performed to check how much LY3372689 gets into the bloodstream and how long the body takes to get rid of it. Each enrolled participant will receive multiple doses of LY3372689 or placebo and will remain in the study for up to eight weeks.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - LY3372689

Administered orally

Drug - Placebo

Administered orally

Additional Information

Official Study Title

Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3372689

Clinical Trial ID

NCT04106206

ParticipAid ID

b2kMKd